Henry Schein (NASDAQ:HSIC) Stock Rating Upgraded by BMO Capital Markets

Henry Schein (NASDAQ:HSIC) was upgraded by analysts at BMO Capital Markets to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Several other research firms have also recently weighed in on HSIC. Robert W. Baird set a $97.00 price objective on shares of Henry Schein in a research report on Wednesday, May 6th. UBS Group reiterated a “neutral” rating and issued a $85.00 target price (down from $87.00) on shares of Henry Schein in a research report on Wednesday, May 6th. Wall Street Zen cut Henry Schein from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Citigroup started coverage on Henry Schein in a research report on Wednesday, April 15th. They set a “buy” rating and a $100.00 price target on the stock. Finally, Mizuho dropped their price target on Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and an average price target of $87.64.

Henry Schein Stock Up 0.8%

HSIC stock opened at $83.86 on Wednesday. The company has a current ratio of 1.36, a quick ratio of 0.75 and a debt-to-equity ratio of 0.59. The company’s 50 day moving average is $77.83 and its 200 day moving average is $77.29. The stock has a market cap of $9.55 billion, a price-to-earnings ratio of 25.34, a price-to-earnings-growth ratio of 1.60 and a beta of 0.81. Henry Schein has a 1-year low of $61.94 and a 1-year high of $89.29.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.12. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The business had revenue of $3.37 billion during the quarter, compared to analyst estimates of $3.34 billion. During the same period in the previous year, the business posted $1.15 earnings per share. Henry Schein’s revenue for the quarter was up 6.3% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Sell-side analysts predict that Henry Schein will post 5.32 EPS for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director William K. Daniel acquired 10,000 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $69.19 per share, with a total value of $691,900.00. Following the purchase, the director owned 20,000 shares of the company’s stock, valued at approximately $1,383,800. This trade represents a 100.00% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.89% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its stake in shares of Henry Schein by 47.3% during the first quarter. AQR Capital Management LLC now owns 30,402 shares of the company’s stock valued at $2,071,000 after buying an additional 9,756 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Henry Schein by 1.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock valued at $1,155,000 after acquiring an additional 229 shares during the last quarter. Acadian Asset Management LLC bought a new stake in shares of Henry Schein in the 1st quarter valued at about $676,000. Cetera Investment Advisers boosted its holdings in Henry Schein by 12.9% during the 2nd quarter. Cetera Investment Advisers now owns 5,561 shares of the company’s stock valued at $406,000 after acquiring an additional 637 shares during the period. Finally, First Trust Advisors LP grew its position in Henry Schein by 0.8% during the 2nd quarter. First Trust Advisors LP now owns 221,130 shares of the company’s stock worth $16,154,000 after acquiring an additional 1,669 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.